Primrose Bio attended BIO International Convention 2025, held June 16–19 at the Boston Convention & Exhibition Center.
Our team shared updates on key platforms, including:
- Enhanced RNA polymerases for more efficient mRNA synthesis
- Next-gen protein expression via our Pfenex Expression Technology®
- CRM197, our industry-leading carrier protein for conjugate vaccines
Representatives from our business development team — Michele Rubino, Louis J. Cantolupo, Jennifer Wittbold, and Alec Tzianabos — were onsite to explore new partnerships and discuss how our technologies can accelerate the path to breakthrough therapies.
